Heavy drinkers may be more likely than other adults to develop dementia, especially in middle age, a French study suggests.
Otonomy, which develops innovative therapeutics for diseases and disorders of the ear, is initiating more job cuts as well as planning to divest one of its assets.
Auris Medical Holding’s HEALOS Phase III clinical trial of AM-111 for acute inner ear hearing loss failed to meet its primary endpoint.
Hearing impairment is already linked to a heightened risk of cognitive decline in old age, and a new study suggests that impaired vision may carry the same risk.
Cochlear Ltd. said it can now stream audio directly from Apple Inc.’s iPhone, iPad and iPod to the microchips in its hearing implants without having to use an additional device.
Learning new things, eating and drinking well, not smoking and limiting hearing loss and loneliness could prevent a third of dementia cases, health experts said.
Doctors have struggled for years to deliver medication effectively to the inner ear, but two companies are vying to be first to introduce new treatments which, if successful, could together chalk up some $800 million in peak sales.